JP2012524708A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012524708A5 JP2012524708A5 JP2011526487A JP2011526487A JP2012524708A5 JP 2012524708 A5 JP2012524708 A5 JP 2012524708A5 JP 2011526487 A JP2011526487 A JP 2011526487A JP 2011526487 A JP2011526487 A JP 2011526487A JP 2012524708 A5 JP2012524708 A5 JP 2012524708A5
- Authority
- JP
- Japan
- Prior art keywords
- dioxo
- methyl
- hydroxymethyl
- trifluoromethylbenzonitrile
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 150000003839 salts Chemical class 0.000 claims 17
- 125000001475 halogen functional group Chemical group 0.000 claims 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 150000001408 amides Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- -1 nitro, hydroxyl Chemical group 0.000 claims 3
- 239000000556 agonist Substances 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- DYJMIXAXRWXZKP-QGZVFWFLSA-N (5s)-3-(3,4-dichlorophenyl)-5-(hydroxymethyl)-1-methyl-5-phenylimidazolidine-2,4-dione Chemical compound C1([C@]2(CO)C(=O)N(C(=O)N2C)C=2C=C(Cl)C(Cl)=CC=2)=CC=CC=C1 DYJMIXAXRWXZKP-QGZVFWFLSA-N 0.000 claims 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 1
- 125000006582 (C5-C6) heterocycloalkyl group Chemical group 0.000 claims 1
- DYJMIXAXRWXZKP-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-5-(hydroxymethyl)-1-methyl-5-phenylimidazolidine-2,4-dione Chemical compound CN1C(=O)N(C=2C=C(Cl)C(Cl)=CC=2)C(=O)C1(CO)C1=CC=CC=C1 DYJMIXAXRWXZKP-UHFFFAOYSA-N 0.000 claims 1
- VAJGULUVTFDTAS-SFHVURJKSA-N 4-[(4r)-4-(hydroxymethyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound C1([C@@]2(CO)C(=O)N(C(=O)N2C)C=2C=C(C(C#N)=CC=2)C(F)(F)F)=CC=CC=C1 VAJGULUVTFDTAS-SFHVURJKSA-N 0.000 claims 1
- VAJGULUVTFDTAS-GOSISDBHSA-N 4-[(4s)-4-(hydroxymethyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound C1([C@]2(CO)C(=O)N(C(=O)N2C)C=2C=C(C(C#N)=CC=2)C(F)(F)F)=CC=CC=C1 VAJGULUVTFDTAS-GOSISDBHSA-N 0.000 claims 1
- ZTRDVSMRQISNQC-UHFFFAOYSA-N 4-[1-[4-cyano-3-(trifluoromethyl)phenyl]-3-methyl-2,5-dioxo-4-phenylimidazolidin-4-yl]-2-methoxy-4-oxobutanoic acid Chemical compound C(#N)C1=C(C=C(C=C1)N1C(N(C(C1=O)(C1=CC=CC=C1)C(CC(C(=O)O)OC)=O)C)=O)C(F)(F)F ZTRDVSMRQISNQC-UHFFFAOYSA-N 0.000 claims 1
- PTJJQSYSALILPG-UHFFFAOYSA-N 4-[3-(cyanomethyl)-4-(hydroxymethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound O=C1C(CO)(C=2C=CC=CC=2)N(CC#N)C(=O)N1C1=CC=C(C#N)C(C(F)(F)F)=C1 PTJJQSYSALILPG-UHFFFAOYSA-N 0.000 claims 1
- HRMVEKRBHVOXMN-UHFFFAOYSA-N 4-[3-ethyl-4-(hydroxymethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound CCN1C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C(=O)C1(CO)C1=CC=CC=C1 HRMVEKRBHVOXMN-UHFFFAOYSA-N 0.000 claims 1
- YNTJLGNYYPSIGY-UHFFFAOYSA-N 4-[4-(1-hydroxyethyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound O=C1C(C(O)C)(C=2C=CC=CC=2)N(C)C(=O)N1C1=CC=C(C#N)C(C(F)(F)F)=C1 YNTJLGNYYPSIGY-UHFFFAOYSA-N 0.000 claims 1
- RRNASESHVQVXMZ-UHFFFAOYSA-N 4-[4-(1-hydroxypropyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound O=C1C(C(O)CC)(C=2C=CC=CC=2)N(C)C(=O)N1C1=CC=C(C#N)C(C(F)(F)F)=C1 RRNASESHVQVXMZ-UHFFFAOYSA-N 0.000 claims 1
- BXIDOXHJFZHDFC-UHFFFAOYSA-N 4-[4-(3-cyanophenyl)-4-(hydroxymethyl)-3-methyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound CN1C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C(=O)C1(CO)C1=CC=CC(C#N)=C1 BXIDOXHJFZHDFC-UHFFFAOYSA-N 0.000 claims 1
- JTPNDBFMZCAXJM-UHFFFAOYSA-N 4-[4-(4-cyanophenyl)-4-(hydroxymethyl)-3-methyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound CN1C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C(=O)C1(CO)C1=CC=C(C#N)C=C1 JTPNDBFMZCAXJM-UHFFFAOYSA-N 0.000 claims 1
- WKRBBSSMYAQKNG-UHFFFAOYSA-N 4-[4-(4-fluorophenyl)-4-(hydroxymethyl)-2,5-dioxo-3-prop-2-ynylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound O=C1C(CO)(C=2C=CC(F)=CC=2)N(CC#C)C(=O)N1C1=CC=C(C#N)C(C(F)(F)F)=C1 WKRBBSSMYAQKNG-UHFFFAOYSA-N 0.000 claims 1
- PUJHVJGPYXFNSZ-UHFFFAOYSA-N 4-[4-(4-fluorophenyl)-4-(hydroxymethyl)-3-methyl-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound CN1C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C(=O)C1(CO)C1=CC=C(F)C=C1 PUJHVJGPYXFNSZ-UHFFFAOYSA-N 0.000 claims 1
- YZZZYXRBSVQHJP-UHFFFAOYSA-N 4-[4-(hydroxymethyl)-2,5-dioxo-4-phenyl-3-prop-1-ynylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound CC#CN1C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C(=O)C1(CO)C1=CC=CC=C1 YZZZYXRBSVQHJP-UHFFFAOYSA-N 0.000 claims 1
- KLOBYTIYOMGQRT-UHFFFAOYSA-N 4-[4-(hydroxymethyl)-2,5-dioxo-4-phenyl-3-propan-2-ylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound CC(C)N1C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C(=O)C1(CO)C1=CC=CC=C1 KLOBYTIYOMGQRT-UHFFFAOYSA-N 0.000 claims 1
- GMPDDOUUFBOTOI-UHFFFAOYSA-N 4-[4-(hydroxymethyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound O=C1C(CO)(C=2C=CC=CC=2)NC(=O)N1C1=CC=C(C#N)C(C(F)(F)F)=C1 GMPDDOUUFBOTOI-UHFFFAOYSA-N 0.000 claims 1
- OLOVCEAMPCAMQA-UHFFFAOYSA-N 4-[4-(hydroxymethyl)-3-methyl-2,5-dioxo-4-[3-(trifluoromethyl)phenyl]imidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound CN1C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C(=O)C1(CO)C1=CC=CC(C(F)(F)F)=C1 OLOVCEAMPCAMQA-UHFFFAOYSA-N 0.000 claims 1
- VAJGULUVTFDTAS-UHFFFAOYSA-N 4-[4-(hydroxymethyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound CN1C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C(=O)C1(CO)C1=CC=CC=C1 VAJGULUVTFDTAS-UHFFFAOYSA-N 0.000 claims 1
- VPWAPLDLNVXBCR-UHFFFAOYSA-N 4-[4-(hydroxymethyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-methoxybenzonitrile Chemical compound C1=C(C#N)C(OC)=CC(N2C(C(CO)(N(C)C2=O)C=2C=CC=CC=2)=O)=C1 VPWAPLDLNVXBCR-UHFFFAOYSA-N 0.000 claims 1
- PONWCDNXABYQOR-UHFFFAOYSA-N 4-[4-(hydroxymethyl)-3-methyl-4-(3-methylphenyl)-2,5-dioxoimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile Chemical compound CN1C(=O)N(C=2C=C(C(C#N)=CC=2)C(F)(F)F)C(=O)C1(CO)C1=CC=CC(C)=C1 PONWCDNXABYQOR-UHFFFAOYSA-N 0.000 claims 1
- NSQGHQGNZIHEOZ-JOCHJYFZSA-N 4-[[(4s)-1-[4-cyano-3-(trifluoromethyl)phenyl]-3-methyl-2,5-dioxo-4-phenylimidazolidin-4-yl]methoxy]-4-oxobutanoic acid Chemical compound C1([C@]2(COC(=O)CCC(O)=O)C(=O)N(C(=O)N2C)C=2C=C(C(C#N)=CC=2)C(F)(F)F)=CC=CC=C1 NSQGHQGNZIHEOZ-JOCHJYFZSA-N 0.000 claims 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 1
- 206010006895 Cachexia Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 201000001880 Sexual dysfunction Diseases 0.000 claims 1
- SGGIBFOETRIEQE-VYLXPPGNSA-N [(2s)-1-[[1-[4-cyano-3-(trifluoromethyl)phenyl]-3-methyl-2,5-dioxo-4-phenylimidazolidin-4-yl]methoxy]-3-methyl-1-oxobutan-2-yl]azanium;chloride Chemical compound [Cl-].O=C1C(COC(=O)[C@@H]([NH3+])C(C)C)(C=2C=CC=CC=2)N(C)C(=O)N1C1=CC=C(C#N)C(C(F)(F)F)=C1 SGGIBFOETRIEQE-VYLXPPGNSA-N 0.000 claims 1
- QDLDKEQDFNJDSH-UHFFFAOYSA-N [1-[4-cyano-3-(trifluoromethyl)phenyl]-3-methyl-2,5-dioxo-4-phenylimidazolidin-4-yl] methyl hydrogen phosphate Chemical compound CN1C(=O)N(C(=O)C1(C2=CC=CC=C2)OP(=O)(O)OC)C3=CC(=C(C=C3)C#N)C(F)(F)F QDLDKEQDFNJDSH-UHFFFAOYSA-N 0.000 claims 1
- 239000003098 androgen Substances 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 208000001076 sarcopenia Diseases 0.000 claims 1
- 231100000872 sexual dysfunction Toxicity 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19191808P | 2008-09-11 | 2008-09-11 | |
| US61/191,918 | 2008-09-11 | ||
| GB0900333.6 | 2009-01-09 | ||
| GB0900333.6A GB2463514C (en) | 2008-09-11 | 2009-01-09 | Imidazolidine compounds and uses therefor |
| PCT/EP2009/061733 WO2010029119A1 (en) | 2008-09-11 | 2009-09-10 | Novel imidazolidine compounds as androgen receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012524708A JP2012524708A (ja) | 2012-10-18 |
| JP2012524708A5 true JP2012524708A5 (enExample) | 2012-11-29 |
| JP5595402B2 JP5595402B2 (ja) | 2014-09-24 |
Family
ID=40379370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526487A Expired - Fee Related JP5595402B2 (ja) | 2008-09-11 | 2009-09-10 | アンドロゲン受容体モジュレーターとしての新規イミダゾリジン化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7968581B2 (enExample) |
| EP (1) | EP2344460B1 (enExample) |
| JP (1) | JP5595402B2 (enExample) |
| KR (1) | KR101705157B1 (enExample) |
| CN (1) | CN102149687B (enExample) |
| AR (1) | AR073282A1 (enExample) |
| AU (1) | AU2009290849B2 (enExample) |
| BR (1) | BRPI0919290A2 (enExample) |
| CA (1) | CA2736364C (enExample) |
| CO (1) | CO6382130A2 (enExample) |
| ES (1) | ES2552684T3 (enExample) |
| GB (1) | GB2463514C (enExample) |
| IL (1) | IL211277A (enExample) |
| MX (1) | MX2011002374A (enExample) |
| NZ (1) | NZ591374A (enExample) |
| RU (1) | RU2488584C2 (enExample) |
| TW (1) | TWI449698B (enExample) |
| WO (1) | WO2010029119A1 (enExample) |
| ZA (1) | ZA201101707B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8168667B2 (en) * | 2006-05-31 | 2012-05-01 | Galapagos Nv | Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
| CN103608333B (zh) * | 2011-03-10 | 2016-01-06 | 苏州开拓药业有限公司 | 雄激素受体拮抗剂及其用途 |
| GB201311107D0 (en) * | 2013-06-21 | 2013-08-07 | Univ Edinburgh | Bioorthogonal methods and compounds |
| CA2918071C (en) * | 2013-07-18 | 2022-04-26 | Baylor College Of Medicine | Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia |
| US20160250188A1 (en) * | 2013-10-25 | 2016-09-01 | Ernest D. Bush | Methods for treatment of muscular dystrophies |
| EP3089975B1 (en) * | 2013-12-31 | 2018-06-06 | Ipsen Pharma S.A.S. | Novel imidazolidine-2, 4-dione derivatives |
| JP7028987B2 (ja) * | 2017-12-06 | 2022-03-02 | アイブライト メディカル テクノロジー （ペキン） カンパニー リミテッド | オルソケラトロジーレンズおよびその製造方法 |
| ES2911428T3 (es) | 2018-04-19 | 2022-05-19 | Tvardi Therapeutics Inc | Inhibidores de STAT3 |
| US11026905B2 (en) | 2018-04-19 | 2021-06-08 | Tvardi Therapeutics, Inc. | STAT3 inhibitors |
| AU2021209679A1 (en) | 2020-01-24 | 2022-06-16 | Tvardi Therapeutics, Inc. | Therapeutic compounds, formulations, and uses thereof |
| CN113024513A (zh) * | 2021-03-22 | 2021-06-25 | 中国药科大学 | 新型雄激素受体降解剂、制备方法和医药用途 |
| CN113801064A (zh) * | 2021-09-26 | 2021-12-17 | 甘肃省化工研究院有限责任公司 | 一种[3+2]环加成反应构建苯基乙内酰脲的方法 |
| EP4539936A1 (en) | 2022-06-15 | 2025-04-23 | Tvardi Therapeutics, Inc. | Prodrugs of stat3 inhibitors |
| CN117327019A (zh) * | 2022-06-23 | 2024-01-02 | 南京思聚生物医药有限公司 | 一种局部作用的雄激素受体拮抗剂的应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5136332B1 (enExample) * | 1970-12-09 | 1976-10-07 | ||
| GB1601310A (en) * | 1978-05-23 | 1981-10-28 | Lilly Industries Ltd | Aryl hydantoins |
| DE2855770A1 (de) | 1978-12-22 | 1980-07-10 | Bayer Ag | Hydantoine |
| US4753957A (en) | 1981-09-28 | 1988-06-28 | Rohm And Haas Company | Substituted 2,4-imidazolidinediones and fungicidal compositions |
| DE3382406D1 (de) | 1982-04-08 | 1991-10-17 | Shell Int Research | Neue hydantoine, ihre herstellung und verwendung. |
| FR2619381B1 (fr) * | 1987-08-13 | 1989-12-08 | Roussel Uclaf | Nouvelles imidazolidines substituees par un radical hydroxymethyle et un radical phenyl substitue, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant et un intermediaire pour leur preparation |
| JP2566792B2 (ja) | 1987-09-30 | 1996-12-25 | 株式会社資生堂 | 発毛、養毛促進剤 |
| JPH0219363A (ja) | 1988-07-06 | 1990-01-23 | Fujisawa Pharmaceut Co Ltd | イミダゾリジン誘導体 |
| US4992443A (en) | 1990-03-12 | 1991-02-12 | William Chelen | Method of treating motion sickness |
| US5346913A (en) | 1992-05-26 | 1994-09-13 | Rohm And Haas Company | N-iodopropargyl hydantoin compounds, compositions, preparation, and use as antimicrobial agents |
| JP3137430B2 (ja) | 1992-06-10 | 2001-02-19 | 鐘淵化学工業株式会社 | ５，５−二置換ヒダントインの製造法 |
| US6846525B2 (en) | 1993-03-19 | 2005-01-25 | Xerox Corporation | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds |
| TW521073B (en) * | 1994-01-05 | 2003-02-21 | Hoechst Marion Roussel Inc | New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them |
| FR2715402B1 (fr) * | 1994-01-05 | 1996-10-04 | Roussel Uclaf | Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
| MX9605218A (es) | 1994-04-29 | 1997-10-31 | Pfizer | Amidas aciclicas y ciclicas novedosas como mejoradores de liberacion de neurotransmisores. |
| EP0760239A3 (en) | 1995-09-01 | 1999-04-14 | Pfizer Inc. | Therapeutic agents for use in cancer therapy |
| FR2741342B1 (fr) | 1995-11-22 | 1998-02-06 | Roussel Uclaf | Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques |
| SK117499A3 (en) * | 1997-03-03 | 2000-05-16 | Boehringer Ingelheim Pharma | Small molecules useful in the treatment of inflammatory and immune cell-mediated diseases, small molecules and pharmaceutical composition with their content |
| US6355664B1 (en) | 1997-03-03 | 2002-03-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease |
| UA57081C2 (uk) | 1997-06-16 | 2003-06-16 | Пфайзер Продактс Інк. | Фармацевтична композиція для лікування раку або доброякісних проліферативних хвороб у ссавців, спосіб лікування, фармацевтична композиція для інгібування ненормального росту клітин у ссавців та спосіб інгібування |
| US6492553B1 (en) | 1998-01-29 | 2002-12-10 | Aventis Pharamaceuticals Inc. | Methods for preparing N-[(aliphatic or aromatic)carbonyl)]-2-aminoaetamide compounds and for cyclizing such compounds |
| EP0945441A3 (de) | 1998-03-27 | 2002-07-17 | Degussa AG | Verfahren zur Herstellung von cyclischen 4-Oxoamidinen |
| CA2408747C (en) | 2000-05-11 | 2011-04-05 | Consejo Superior Investigaciones Cientificas | Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| US6846643B2 (en) | 2000-08-14 | 2005-01-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy |
| AU2005285035B2 (en) * | 2004-09-10 | 2012-03-22 | Janssen Pharmaceutica N.V. | Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) |
| CN102304075A (zh) | 2005-10-11 | 2012-01-04 | 因特蒙公司 | 病毒复制抑制剂 |
| GB0610765D0 (en) * | 2006-05-31 | 2006-07-12 | Proskelia Sas | Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
-
2009
- 2009-01-09 GB GB0900333.6A patent/GB2463514C/en not_active Expired - Fee Related
- 2009-09-09 AR ARP090103461A patent/AR073282A1/es unknown
- 2009-09-10 MX MX2011002374A patent/MX2011002374A/es active IP Right Grant
- 2009-09-10 WO PCT/EP2009/061733 patent/WO2010029119A1/en not_active Ceased
- 2009-09-10 AU AU2009290849A patent/AU2009290849B2/en not_active Ceased
- 2009-09-10 BR BRPI0919290-5A patent/BRPI0919290A2/pt not_active Application Discontinuation
- 2009-09-10 NZ NZ591374A patent/NZ591374A/en not_active IP Right Cessation
- 2009-09-10 US US12/557,368 patent/US7968581B2/en active Active
- 2009-09-10 EP EP09782854.5A patent/EP2344460B1/en active Active
- 2009-09-10 ES ES09782854.5T patent/ES2552684T3/es active Active
- 2009-09-10 CN CN200980135475.9A patent/CN102149687B/zh not_active Expired - Fee Related
- 2009-09-10 RU RU2011113749/04A patent/RU2488584C2/ru not_active IP Right Cessation
- 2009-09-10 KR KR1020117007686A patent/KR101705157B1/ko not_active Expired - Fee Related
- 2009-09-10 JP JP2011526487A patent/JP5595402B2/ja not_active Expired - Fee Related
- 2009-09-10 CA CA2736364A patent/CA2736364C/en not_active Expired - Fee Related
- 2009-09-11 TW TW098130825A patent/TWI449698B/zh not_active IP Right Cessation
-
2011
- 2011-02-17 IL IL211277A patent/IL211277A/en not_active IP Right Cessation
- 2011-03-04 ZA ZA2011/01707A patent/ZA201101707B/en unknown
- 2011-04-08 CO CO11043783A patent/CO6382130A2/es not_active Application Discontinuation
- 2011-06-23 US US13/167,682 patent/US8383608B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011113749A (ru) | Новые имидазолидиновые соединения как модуляторы андрогенных рецепторов | |
| JP2010535704A5 (enExample) | ||
| RU2439068C2 (ru) | Модуляторы mglur5 | |
| JP2011502958A5 (enExample) | ||
| RU2365588C2 (ru) | Хиназолиновые соединения | |
| JP2005536475A5 (enExample) | ||
| JP2018502906A5 (enExample) | ||
| FI3897636T3 (fi) | Substituoituja 3-((3-aminofenyyli)amino)piperidiini-2,6-dioniyhdisteitä, niiden koostumuksia ja menetelmiä niillä annettavia hoitoja varten | |
| CY1107433T1 (el) | Παραγωγα 1-(2η-πυραζολ-3-υλο)-3-(4-[1-(βενζοϋλο)-πιπepιδιν-4-υλομεθυλο]-φαινυλο)-ουριας και συναφεις ενωσεις ως αναστολεις της ρ38 κινασης και/ή tnf-αναστολεις για την αντιμετωπιση φλεγμονων | |
| NZ593030A (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
| RU2481330C2 (ru) | Азотсодержащее ароматическое гетероциклическое соединение | |
| JP2008540554A5 (enExample) | ||
| RU2010110640A (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| JP2014511869A5 (enExample) | ||
| JP2019537603A5 (enExample) | ||
| JP2012533546A5 (enExample) | ||
| RU2017126187A (ru) | 5-[(пиперазин-1-ил)-3-оксо-пропил]-имидазолидин-2,4-дионовые производные в качестве ингибиторов adamts для лечения остеоартрита | |
| JP2016540811A5 (enExample) | ||
| PE20110433A1 (es) | Antagonistas de la via hedgehog de ftalazina disustituida | |
| RU2005131165A (ru) | Производные имидазол-4-илэтинилпиридина | |
| JP2017502063A5 (enExample) | ||
| JOP20190113A1 (ar) | مثبطات بروتون تيروزين كيناز | |
| JP2012507535A5 (enExample) | ||
| EA200970341A1 (ru) | Пиразолиновые соединения в качестве антагонистов минералокортикоидных рецепторов | |
| JP2017500321A5 (enExample) |